Impression Healthcare (#ASX: $IHL) will discontinue oral devices business by 30th June 2020 and focus on #cannabinoid sales and development activities. $IHL expects higher quarterly revenue than pcp. https://t.co/MX47MNEdxY. #stocks https://t.co/XncMnxhvIX